Salarius Pharmaceuticals Inc [SLRX] stock prices are up 0.49% to $0.65 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SLRX shares have gain 2.52% over the last week, with a monthly amount drifted -23.78%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Salarius Pharmaceuticals Inc [NASDAQ: SLRX] stock has seen the most recent analyst activity on April 27, 2020, when Ladenburg Thalmann initiated its Buy rating and assigned the stock a price target of $3.80.
The stock price of Salarius Pharmaceuticals Inc [SLRX] has been fluctuating between $0.62 and $108.00 over the past year. Salarius Pharmaceuticals Inc [NASDAQ: SLRX] shares were valued at $0.65 at the most recent close of the market.
Analyzing the SLRX fundamentals
Gross Profit Margin for this corporation currently stands at 0.0% with Operating Profit Margin at -1138.43%, Pretax Profit Margin comes in at -1130.76%, and Net Profit Margin reading is -1130.76%. To continue investigating profitability, this company’s Return on Assets is posted at -0.82, Equity is -4.01 and Total Capital is -1.01.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.6387 points at the first support level, and at 0.6255 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.6676, and for the 2nd resistance point, it is at 0.6833.
Ratios To Look Out For
It’s worth pointing out that Salarius Pharmaceuticals Inc [NASDAQ:SLRX]’s Current Ratio is 2.79. Further, the Quick Ratio stands at 2.79, while the Cash Ratio is 4.36.
Transactions by insiders
Recent insider trading involved HANISH ARNOLD C, Director, that happened on Dec 30 ’25 when 15.0 shares were sold. Director, HANISH ARNOLD C completed a deal on Dec 30 ’25 to sell 12.0 shares. Meanwhile, Director HANISH ARNOLD C bought 5000.0 shares on Nov 20 ’25.
